136 related articles for article (PubMed ID: 26284426)
1. A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.
Otto C; Särnefält A; Ljungars A; Wolf S; Rohde-Schulz B; Fuchs I; Schkoldow J; Mattsson M; Vonk R; Harrenga A; Freiberg C
Endocrinology; 2015 Nov; 156(11):4365-73. PubMed ID: 26284426
[TBL] [Abstract][Full Text] [Related]
2. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.
Hovey RC; Trott JF; Ginsburg E; Goldhar A; Sasaki MM; Fountain SJ; Sundararajan K; Vonderhaar BK
Dev Dyn; 2001 Oct; 222(2):192-205. PubMed ID: 11668597
[TBL] [Abstract][Full Text] [Related]
4. Characterization of multiple first exons in murine prolactin receptor gene and the effect of prolactin on their expression in the choroid plexus.
Tabata H; Kobayashi M; Ikeda JH; Nakao N; Saito TR; Tanaka M
J Mol Endocrinol; 2012 Apr; 48(2):169-76. PubMed ID: 22294444
[TBL] [Abstract][Full Text] [Related]
5. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
Ueda EK; Huang K; Nguyen V; Ferreira M; Andre S; Walker AM
Cell Tissue Res; 2011 Nov; 346(2):175-89. PubMed ID: 22081226
[TBL] [Abstract][Full Text] [Related]
6. A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice.
Binart N; Imbert-Bollore P; Baran N; Viglietta C; Kelly PA
Mol Endocrinol; 2003 Jun; 17(6):1066-74. PubMed ID: 12624115
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of the prolactin receptor expression in human breast cancer.
Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
[TBL] [Abstract][Full Text] [Related]
8. Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.
Shao R; Nutu M; Weijdegård B; Egecioglu E; Fernandez-Rodriguez J; Tallet E; Goffin V; Ling C; Billig H
Biol Reprod; 2008 Oct; 79(4):748-57. PubMed ID: 18596217
[TBL] [Abstract][Full Text] [Related]
9. Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice.
Craven AJ; Ormandy CJ; Robertson FG; Wilkins RJ; Kelly PA; Nixon AJ; Pearson AJ
Endocrinology; 2001 Jun; 142(6):2533-9. PubMed ID: 11356702
[TBL] [Abstract][Full Text] [Related]
10. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
Kan QE; Su Y; Yang H; Man H
Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
[TBL] [Abstract][Full Text] [Related]
11. Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist.
Lan H; Hong P; Li R; L S; Anshan S; Li S; Zheng X
Mol Immunol; 2017 Jul; 87():86-93. PubMed ID: 28412548
[TBL] [Abstract][Full Text] [Related]
12. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
13. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.
Grimm SL; Seagroves TN; Kabotyanski EB; Hovey RC; Vonderhaar BK; Lydon JP; Miyoshi K; Hennighausen L; Ormandy CJ; Lee AV; Stull MA; Wood TL; Rosen JM
Mol Endocrinol; 2002 Dec; 16(12):2675-91. PubMed ID: 12456789
[TBL] [Abstract][Full Text] [Related]
14. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice.
Ling C; Hellgren G; Gebre-Medhin M; Dillner K; Wennbo H; Carlsson B; Billig H
Endocrinology; 2000 Oct; 141(10):3564-72. PubMed ID: 11014209
[TBL] [Abstract][Full Text] [Related]
15. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
Standing D; Dandawate P; Anant S
Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
[TBL] [Abstract][Full Text] [Related]
16. Immune system development and function in prolactin receptor-deficient mice.
Bouchard B; Ormandy CJ; Di Santo JP; Kelly PA
J Immunol; 1999 Jul; 163(2):576-82. PubMed ID: 10395643
[TBL] [Abstract][Full Text] [Related]
17. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
Cui H; Ma YZ; Wang Y; Song M; Zhang H
Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
[TBL] [Abstract][Full Text] [Related]
19. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
20. Socs2 and elf5 mediate prolactin-induced mammary gland development.
Harris J; Stanford PM; Sutherland K; Oakes SR; Naylor MJ; Robertson FG; Blazek KD; Kazlauskas M; Hilton HN; Wittlin S; Alexander WS; Lindeman GJ; Visvader JE; Ormandy CJ
Mol Endocrinol; 2006 May; 20(5):1177-87. PubMed ID: 16469767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
